ENTOURAGE HEALTH CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.01 CAD | 0.00% |
|
-33.33% | -33.33% |
| Apr. 30 | Entourage Health Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Jan. 31 | Entourage Health Corp. Announces Resignation of Lu Cacioppo from its Board of Directors | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 145.8 | 160.4 | 51.51 | 24.32 | 6.135 | 4.626 |
| Enterprise Value (EV) 1 | 122.9 | 199.6 | 109.8 | 108.3 | 131.6 | 155.1 |
| P/E ratio | -131 x | -9.56 x | -0.57 x | -0.25 x | -0.05 x | -0.1 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 18.3 x | 7.7 x | 1.75 x | 0.58 x | 0.15 x | 0.11 x |
| EV / Revenue | 15.5 x | 9.58 x | 3.73 x | 2.56 x | 3.22 x | 3.81 x |
| EV / EBITDA | -11.8 x | -24.5 x | -2.02 x | -2.9 x | -2.88 x | -7.06 x |
| EV / FCF | -2.8 x | -2.68 x | -2.95 x | -4.85 x | -3.92 x | -16.7 x |
| FCF Yield | -35.7% | -37.3% | -33.9% | -20.6% | -25.5% | -6% |
| Price to Book | 1.89 x | 1.18 x | 0.7 x | 1.13 x | -0.06 x | -0.03 x |
| Nbr of stocks (in thousands) | 111,271 | 186,490 | 210,262 | 303,977 | 306,744 | 308,387 |
| Reference price 2 | 1.310 | 0.8600 | 0.2450 | 0.0800 | 0.0200 | 0.0150 |
| Announcement Date | 4/30/19 | 6/10/20 | 5/31/21 | 5/9/22 | 5/1/23 | 4/30/24 |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 7.955 | 20.82 | 29.43 | 42.27 | 40.89 | 40.71 |
| EBITDA 1 | -10.43 | -8.135 | -54.49 | -37.29 | -45.66 | -21.96 |
| EBIT 1 | -10.53 | -8.363 | -56.64 | -44.04 | -51.51 | -22.34 |
| Operating Margin | -132.4% | -40.17% | -192.43% | -104.18% | -125.96% | -54.88% |
| Earnings before Tax (EBT) 1 | -0.8951 | -10.39 | -89.61 | -78.94 | -123.1 | -46.17 |
| Net income 1 | -0.8951 | -10.39 | -89.61 | -78.94 | -123.1 | -46.17 |
| Net margin | -11.25% | -49.91% | -304.43% | -186.73% | -301.15% | -113.4% |
| EPS 2 | -0.0100 | -0.0900 | -0.4307 | -0.3170 | -0.4037 | -0.1500 |
| Free Cash Flow 1 | -43.86 | -74.42 | -37.29 | -22.33 | -33.57 | -9.304 |
| FCF margin | -551.38% | -357.45% | -126.69% | -52.83% | -82.09% | -22.85% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 4/30/19 | 6/10/20 | 5/31/21 | 5/9/22 | 5/1/23 | 4/30/24 |
1CAD in Million2CAD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | 39.2 | 58.3 | 83.9 | 125 | 150 |
| Net Cash position 1 | 22.8 | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | -4.816 x | -1.07 x | -2.251 x | -2.748 x | -6.851 x |
| Free Cash Flow 1 | -43.9 | -74.4 | -37.3 | -22.3 | -33.6 | -9.3 |
| ROE (net income / shareholders' equity) | -1.75% | -9.75% | -85.3% | -165% | 309% | 37.2% |
| ROA (Net income/ Total Assets) | -10.3% | -3.51% | -18.6% | -17.4% | -33.8% | -35.9% |
| Assets 1 | 8.681 | 296.1 | 482.4 | 452.5 | 364.7 | 128.7 |
| Book Value Per Share 2 | 0.6900 | 0.7300 | 0.3500 | 0.0700 | -0.3300 | -0.4800 |
| Cash Flow per Share 2 | 0.1900 | 0.0400 | 0.1100 | 0.0700 | 0.0300 | 0.0400 |
| Capex 1 | 36.5 | 55.3 | 1.18 | 0.45 | 1.7 | 1.2 |
| Capex / Sales | 458.51% | 265.57% | 4.02% | 1.06% | 4.15% | 2.95% |
| Announcement Date | 4/30/19 | 6/10/20 | 5/31/21 | 5/9/22 | 5/1/23 | 4/30/24 |
1CAD in Million2CAD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -33.33% | 2.25M | |
| +39.75% | 4.17B | |
| +148.03% | 2.33B | |
| +138.10% | 78.45M |
- Stock Market
- Equities
- ENTG Stock
- Financials Entourage Health Corp.